Claudio A Schioppa

3PUBLICATIONS
25CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 30, 2025
Overall survival outcomes with first-line continuous ibrutinib and fixed-duration ibrutinib-venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an age-matched European population.

Paolo Ghia, Loic Ysebaert, Ann Janssens

|Nov 25, 2023
Amivantamab Compared with Real-World Physician's Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations.

Petros Christopoulos, Nicolas Girard, Claudia Proto

|Jan 18, 2023
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.

Christos Chouaid, Lise Bosquet, Nicolas Girard

Pageof 1

Frequent Collaborators

2 joint publications

Joris Diels

1 joint publications

Christos Chouaid

1 joint publications

Lise Bosquet

1 joint publications

Nicolas Girard